ReCode Therapeutics

Developer of targeted delivery technology designed for patients with rare diseases. The company's platform utilizes lipid nanoparticles to precisely deliver corrective or disease-modifying genetic the...

Healthcare
Menlo Park, CA, United States
Founded 2015
105 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$388M
Last Round
N/A

Get the full picture

Create a free account to unlock ReCode Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required